Financing Overview - A total of 11 financing events occurred in Shanghai this week, with 6 disclosing amounts totaling approximately 390 million yuan [3][7] - The highest number of financing events took place in Songjiang District with 3 occurrences, followed by Pudong New District with 2 [3] Company Financing Dynamics - NeuShen Therapeutics completed a multi-million dollar Series A financing on April 18, led by Shanghai Biomedical Fund, with existing shareholders also participating. The funds will be used to advance clinical development of its core product NS-041 [13][14] - QiSeLian Biotechnology announced the completion of its angel round financing on April 17, focusing on personalized cell therapy and anti-aging technology [15][16] - WeiTi Robotics secured nearly 100 million yuan in angel and angel+ round financing on April 15, with investments from various venture capital firms. The funds will support the development of its bionic perception systems [17][18] - FuKe New Materials completed a Pre-A round financing of several tens of millions on April 15, aimed at enhancing its eco-friendly waterproof and oil-proof agents [19][20] - YiRen Technology completed a Pre-A round financing of several tens of millions on April 19, focusing on spatiotemporal intelligent data services [22][24] - DeYin Technology announced the completion of several tens of millions in angel round financing on April 18, aimed at expanding its elderly care robot product line [25][26] - JuErDa Technology secured 12 million yuan in angel round financing on April 17, focusing on cybersecurity solutions [27][28] - LiangWei Technology completed an angel+ round financing on April 14, focusing on interface-free material development [29][30] - JinZe Biotechnology completed a Pre-A round financing on April 14, focusing on intelligent detection and intervention products for cognitive disorders [31][32] - YunShen Technology completed an A round financing on April 14, focusing on semiconductor materials and equipment [33][34] - ShangGuang Communication completed an A+ round financing on April 15, focusing on laser communication technology [35][36] Industry Focus - The medical health sector saw 3 financing events this week, focusing on cell therapy, chemical preparations, and in vitro diagnostics [10][37] - The release of the first "White Paper on the Survival Status of Small Cell Lung Cancer Patients in China" highlights challenges in clinical diagnosis and patient survival [37] - Recent government policies are fostering high-quality development in the pharmaceutical industry, with a focus on innovative drugs and cell therapy, particularly in Shanghai, which has become a leader in this field [38]
上海11家企业完成新一轮融资 | 融资周报（2025年第13期）
Sou Hu Cai Jing·2025-04-22 10:58